Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development
- 1 April 2001
- Vol. 19 (20-22) , 2769-2782
- https://doi.org/10.1016/s0264-410x(00)00536-3
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccinesVirus Research, 1994
- Respiratory syncytial virus puzzle: Clinical features, pathophysiology, treatment, and preventionThe Journal of Pediatrics, 1992
- Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwideVirus Research, 1992
- Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian childrenThe Journal of Pediatrics, 1992
- Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infectionThe Journal of Pediatrics, 1992
- Relationship of parental smoking to wheezing and nonwheezing lower respiratory tract illnesses in infancyThe Journal of Pediatrics, 1991
- Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virusVaccine, 1990
- Modes of transmission of respiratory syncytial virusThe Journal of Pediatrics, 1981
- Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levelThe Journal of Pediatrics, 1981
- Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunityThe Journal of Pediatrics, 1980